Research Paper Volume 16, Issue 7 pp 6163—6187
KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer
Figure 6. ESTIMATE scores distribution and TIICs analysis by CIBERSORT. (A–C) Distribution of ISs, SSs, and ESs between KIF3C high- and low-expression groups. (D) A bar chart showing the difference in the proportion of 22 TIICs in the TME of STAD. (E) A boxplot comparing the proportion of the 22 TIICs in the TME of STAD between the high- and low-expression groups (* p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant).